MedWorm: Allergy & Immunology Clinical Trials

Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy

ClinicalTrials.gov — Tue, 30 Apr 2013 16:00:00 +0100

Condition: Food AllergyInterventions: Drug: Egg Oral Immunotherapy; Drug: Baked EggSponsors: Mount Sinai School of Medicine; Hugh.Sampson; National Institute of Allergy and Infectious Diseases (NIAID); Consortium of Food Allergy ResearchNot yet recruiting - verified April 2013 (Source: ClinicalTrials.gov)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use

ClinicalTrials.gov — Wed, 27 Mar 2013 16:00:00 +0100

Conditions: Rabies Vaccine Allergy; Vaccination Adverse Event; Anti-D AntibodiesInterventions: Biological: Zagreb2-1-1; Biological: EssenSponsors: Beijing Center for Disease Control and Prevention; Beijing Center for Disease Control and PreventionRecruiting - verified April 2013 (Source: ClinicalTrials.gov)

Intranasal AD4-H5-VTN as an Adenovirus Vaccine

ClinicalTrials.gov — Wed, 06 Mar 2013 17:00:00 +0100

Condition: Healthy VolunteerIntervention: Biological: Ad4-H5-VtnSponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified February 2013 (Source: ClinicalTrials.gov)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Circassia?s Toleromune Cat Allergy Treatment Maintains Symptom Improvement Two Years After Start of Short-Course Therapy

Drugs.com - Clinical Trials — Mon, 25 Feb 2013 18:25:34 +0100

OXFORD, UK and SAN ANTONIO, USA – 25 February 2013 – Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of... (Source: Drugs.com - Clinical Trials)

GREER Investigational Sublingual Allergy Immunotherapy Liquid (SAIL) for Short Ragweed Allergies Data From Phase III Trial Featured at Allergy Meeting

Drugs.com - Clinical Trials — Mon, 25 Feb 2013 15:50:41 +0100

First Positive Findings from a Phase III Trial Evaluating Sublingual-Liquid Ragweed Pollen Extract in North America Presented at a Featured Poster Session at Prominent Allergy Meeting SAN ANTONIO--(BUSINESS WIRE)--Feb 25, 2013 - GREER®,... (Source: Drugs.com - Clinical Trials)

Circassia's ToleroMune Cat Allergy Treatment Maintains Symptom Improvement Two Years After Start of Short-Course Therapy

Drugs.com - Clinical Trials — Mon, 25 Feb 2013 13:09:42 +0100

OXFORD, England and SAN ANTONIO, February 25, 2013 /PRNewswire/ --Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing that a short course of just four doses of... (Source: Drugs.com - Clinical Trials)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Dyax Presents DX-2930 Data at the 2013 American Academy of Allergy, Asthma and Immunology Annual Meeting

Drugs.com - Clinical Trials — Mon, 25 Feb 2013 12:17:14 +0100

DX-2930 is a Potent, Highly Specific, and Potentially Long-Acting Antibody Inhibitor of Plasma Kallikrein BURLINGTON, Mass.--(BUSINESS WIRE)--Feb 25, 2013 - Dyax Corp. (NASDAQ:DYAX) today announced results from a preclinical study of DX-2930, their... (Source: Drugs.com - Clinical Trials)

Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status

Drugs.com - Clinical Trials — Mon, 25 Feb 2013 12:16:49 +0100

Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status Data presented at the 2013 American Academy of Allergy, Asthma & Immunology Annual Meeting San Antonio, Texas, Feb. 23, 2013... (Source: Drugs.com - Clinical Trials)

Additional QNASL (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting

Drugs.com - Clinical Trials — Fri, 22 Feb 2013 13:24:19 +0100

Data to be Presented Regarding Impact on Sleep Quality and Nasal Symptom Relief at 24 Hours Post Dose in Patients with Seasonal and Perennial Allergic Rhinitis JERUSALEM--(BUSINESS WIRE)--Feb 22, 2013 - Teva Pharmaceutical Industries Ltd. announced... (Source: Drugs.com - Clinical Trials)

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart

ClinicalTrials.gov — Wed, 30 Jan 2013 17:00:00 +0100

Condition: DengueInterventions: Biological: TV003 Vaccine; Biological: Placebo VaccineSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified January 2013 (Source: ClinicalTrials.gov)

Details of HER-2/neu Class I Antigen Licensed by TapImmune published in Journal of Immunology: Antigen is a naturally processed epitope for breast cancer vaccines.

Drugs.com - Clinical Trials — Sat, 26 Jan 2013 00:30:35 +0100

SEATTLE, Jan. 22, 2013 /PRNewswire/ -- TapImmune Inc. (OTCBB: TPIV) is pleased to announce the January publication of a paper titled "Enzymatic Discovery of a HER-2/neu Epitope That Generates Cross-Reactive T-cells", authored by Henle et al,... (Source: Drugs.com - Clinical Trials)

Children with egg allergies can safely receive flu vaccine, U-M study says

Drugs.com - Clinical Trials — Fri, 25 Jan 2013 23:48:48 +0100

Egg allergic children did not have adverse reactions to single dose of influenza vaccine in multi-center study ANN ARBOR, Mich., Jan. 22, 2013 /PRNewswire-USNewswire/ -- Egg allergic children, including those with a history of anaphylaxis to egg,... (Source: Drugs.com - Clinical Trials)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer

ClinicalTrials.gov — Wed, 16 Jan 2013 17:00:00 +0100

Condition: NeoplasmsIntervention: Genetic: Blood and tumor samplesSponsors: Centre Leon Berard; Centre Leon BerardNot yet recruiting - verified January 2013 (Source: ClinicalTrials.gov)

CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1

ClinicalTrials.gov — Thu, 10 Jan 2013 17:00:00 +0100

Conditions: Abnormal Glucose Tolerance; Type 1 DiabetesInterventions: Drug: CTLA4-Ig (Abatacept); Drug: PlaceboSponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); American Diabetes Association; Juvenile Diabetes Research FoundationNot yet recruiting - verified January 2013 (Source: ClinicalTrials.gov)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Single Administration of GenVec's Vaccine Provides Protective Immunity Against HSV in Pre-clinical Animal Models

Drugs.com - Clinical Trials — Mon, 17 Dec 2012 20:37:08 +0100

GAITHERSBURG, Md., Dec. 17, 2012 /PRNewswire/ -- GenVec, Inc. (NASDAQ:GNVC) announced today that data were presented on its HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms of Vaccination, which is taking place... (Source: Drugs.com - Clinical Trials)

NIH-Funded Trial Launched to Assess Experimental TB Drug

Drugs.com - Clinical Trials — Wed, 12 Dec 2012 12:49:58 +0100

A clinical trial will examine an investigational drug's early bacteria-killing activity in patients newly diagnosed with drug-sensitive pulmonary tuberculosis. The clinical trial -- sponsored by the National Institute of Allergy and... (Source: Drugs.com - Clinical Trials)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Compugen Presents at American Association of Cancer Research Special Conference on Tumor Immunology

Drugs.com - Clinical Trials — Tue, 04 Dec 2012 12:33:10 +0100

Presentation includes new results supporting use of two Compugen immune checkpoint target candidates in cancer immunotherapy MIAMI--(BUSINESS WIRE)--Dec 4, 2012 - Speaking today at the American Association of Cancer Research Special Conference on... (Source: Drugs.com - Clinical Trials)

Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study

ClinicalTrials.gov — Tue, 27 Nov 2012 17:00:00 +0100

Condition: Dermatitis, AtopicInterventions: Biological: Fluzone® Intradermal Vaccine; Biological: Fluzone® (Intramuscular) vaccineSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); The Atopic Dermatitis Research Network (ADRN)Recruiting - verified November 2012 (Source: ClinicalTrials.gov)

ViroPharma's Cinryze (C1 Esterase Inhibitor [Human]) Prophylaxis Study Showed Safety Data of Escalating Doses in Patients With Hereditary Angioedema

Drugs.com - Clinical Trials — Tue, 13 Nov 2012 13:06:01 +0100

- Safety and Efficacy of Escalating Doses Presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) - EXTON, Pa., Nov. 13, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced... (Source: Drugs.com - Clinical Trials)

Phase III Data for Teva's QNASL (beclomethasone dipropionate) Demonstrate Efficacy Profile in Pediatric Patients with Seasonal Allergic Rhinitis

Drugs.com - Clinical Trials — Fri, 09 Nov 2012 13:35:31 +0100

Additional Phase III Data Show Long-Term Ocular Safety Profile and Support Device Functionality and Reliability JERUSALEM--(BUSINESS WIRE)--Nov 9, 2012 - Teva Pharmaceutical Industries Ltd. announced today additional data from the Phase III clinical... (Source: Drugs.com - Clinical Trials)

New Data From UCB's Immunology Portfolio Highlighted at 2012 American College of Rheumatology Meeting

Drugs.com - Clinical Trials — Fri, 09 Nov 2012 13:04:43 +0100

Guide for science writers: UCB-sponsored data on Cimzia® (certolizumab pegol) for Rheumatoid Arthritis and other research from development pipeline ATLANTA and BRUSSELS, Nov. 9, 2012 /PRNewswire/ -- UCB, a global biopharmaceutical company... (Source: Drugs.com - Clinical Trials)

Cleveland BioLabs Announces Publication of Studies on Effect of Entolimod (CBLB502) on Graft-Versus-Tumor Activity in Models of Allogeneic Bone Marrow Transplantation

Drugs.com - Clinical Trials — Tue, 06 Nov 2012 20:06:17 +0100

BUFFALO, N.Y., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) announced today the online publication in the Journal of Immunology of a study demonstrating efficacy of Entolimod(TM) (previously known as CBLB502) in improving... (Source: Drugs.com - Clinical Trials)

Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting

Drugs.com - Clinical Trials — Fri, 02 Nov 2012 15:35:40 +0100

NEW BRUNSWICK, N.J., Nov. 2, 2012 /PRNewswire/ -- Janssen and Johnson & Johnson (NYSE: JNJ) will provide a pre-recorded webcast for investors and other interested parties on Saturday, November 10, at approximately 5:00 p.m., Eastern Time, to... (Source: Drugs.com - Clinical Trials)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting

Drugs.com - Clinical Trials — Fri, 02 Nov 2012 15:11:40 +0100

Optical Imaging and User Perception Study of Vaginal Gel

ClinicalTrials.gov — Wed, 24 Oct 2012 16:00:00 +0100

Conditions: Characterize Gel Distribution in the Vagina; Study Women's Sensory Perceptions and Preferences of GelInterventions: Other: vaginal gel imaging; Behavioral: computer aided self interviewSponsors: Duke University; Duke University; National Institute of Allergy and Infectious Disease (NIAID); ImQuest Pharmaceuticals, Inc.; The Miriam HospitalNot yet recruiting - verified October 2012 (Source: ClinicalTrials.gov)

Cell Therapeutics' Unique Orally Available, Multi-Kinase (JAK2, FLT3, c-Fms) Inhibitor CT-1578 Demonstrates Ability to Prevent the Onset of Rheumatoid Arthritis and Potency in Treating and Reversing Bone and Cartilage Damage In Preclinical Models

Drugs.com - Clinical Trials — Mon, 15 Oct 2012 12:55:44 +0100

Results Reported in the Journal of Immunology SEATTLE, Oct. 15, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that CT-1578's (previously known as SB-1578) unique kinase spectrum that selectively inhibits... (Source: Drugs.com - Clinical Trials)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Inovio Pharmaceuticals' Synthetic Vaccines Delivered with Minimally Invasive Skin Electroporation Technology Generate Potent Immune Responses

Drugs.com - Clinical Trials — Tue, 09 Oct 2012 00:09:23 +0100

New Preclinical Data Paves Way for Large Scale Vaccine Administration BLUE BELL, Pa., Oct. 4, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today the publication of positive immunological effects in preclinical... (Source: Drugs.com - Clinical Trials)

Compugen Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance

Drugs.com - Clinical Trials — Mon, 10 Sep 2012 19:40:46 +0100

Suggested mode of action for CGEN-15001 directly impacts key pathogenic aspects of autoimmune disease Results from pre-clinical studies for CGEN-15001 immune checkpoint modulator presented at the European Congress of Immunology TEL AVIV,... (Source: Drugs.com - Clinical Trials)

Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)

ClinicalTrials.gov — Fri, 31 Aug 2012 16:00:00 +0100

Conditions: Rhinitis, Allergic, Perennial; Rhinitis, Allergic, NonseasonalInterventions: Biological: MK-8237 6 DU; Biological: MK-8237 12 DU; Biological: PlaceboSponsors: Merck; MerckNot yet recruiting - verified August 2012 (Source: ClinicalTrials.gov)